CD1 expression in human atherosclerosis -: A potential mechanism for T cell activation by foam cells

被引:103
作者
Melián, A
Geng, YJ
Sukhova, GK
Libby, P
Porcelli, SA
机构
[1] Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Dept Med, Div Cardiol, Boston, MA 02115 USA
[3] Allegheny Univ Hlth Sci, Cardiovasc & Pulm Res Inst, Pittsburgh, PA USA
关键词
D O I
10.1016/S0002-9440(10)65176-0
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Atherosclerotic plaques are chronic inflammatory lesions composed of dysfunctional endothelium, smooth muscle cells, lipid-laden macrophages, and T lymphocytes. This study analyzed atherosclerotic tissue specimens for expression of CD1 molecules, a family of cell surface proteins that present lipid antigens to T cells, and examined the possibility that CD1+ lipid-laden macrophages might present antigen to T cells. Immunohistochemical studies using a panel of specific monoclonal antibodies demonstrated expression of each of the four previously characterized human CD1 proteins (CD1a, -b, -c, and -d) in atherosclerotic plaques, Expression of CD1 was not observed in normal arterial specimens and appeared to be restricted to the CD68+ lipid-laden foam cells of atherosclerotic lesions. CD1 molecules colocalized in areas of the arterial wall that also contained abundant T lymphocytes, suggesting potential interactions between CD1+ cells and plaque-infiltrating lymphocytes in situ. Using CD1-expressing foam cells derived from macrophages in vitro,we demonstrated the ability of such cells to present lipid antigens to CD1 restricted T cells, Given the abundant T cells, CD1+ macrophages, and lipid accumulation in atherosclerotic plaques, we propose a potential role for lipid antigen presentation by CD1 proteins in the generation of the inflammatory component of these lesions.
引用
收藏
页码:775 / 786
页数:12
相关论文
共 69 条
[21]   IFN-gamma potentiates atherosclerosis in apoE knock-out mice [J].
Gupta, S ;
Pablo, AM ;
Jiang, XC ;
Wang, N ;
Tall, AR ;
Schindler, C .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (11) :2752-2761
[22]   LOCALIZATION OF LYMPHOCYTES-T AND MACROPHAGES IN FIBROUS AND COMPLICATED HUMAN ATHEROSCLEROTIC PLAQUES [J].
HANSSON, GK ;
JONASSON, L ;
LOJSTHED, B ;
STEMME, S ;
KOCHER, O ;
GABBIANI, G .
ATHEROSCLEROSIS, 1988, 72 (2-3) :135-141
[23]   IMMUNE-MECHANISMS IN ATHEROSCLEROSIS [J].
HANSSON, GK ;
JONASSON, L ;
SEIFERT, PS ;
STEMME, S .
ARTERIOSCLEROSIS, 1989, 9 (05) :567-578
[24]  
HANSSON GK, 1989, AM J PATHOL, V135, P169
[25]   EXPRESSION OF CLASS-II TRANSPLANTATION ANTIGEN ON VASCULAR SMOOTH-MUSCLE CELLS IN HUMAN ATHEROSCLEROSIS [J].
JONASSON, L ;
HOLM, J ;
SKALLI, O ;
GABBIANI, G ;
HANSSON, GK .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (01) :125-131
[26]   Natural ligand of mouse CD1d1: Cellular glycosylphosphatidylinositol [J].
Joyce, S ;
Woods, AS ;
Yewdell, JW ;
Bennink, JR ;
De Silva, AD ;
Boesteanu, A ;
Balk, SP ;
Cotter, RJ ;
Brutkiewicz, RR .
SCIENCE, 1998, 279 (5356) :1541-1544
[27]   Importance of minor histocompatibility antigens in the development of allograft arteriosclerosis [J].
Koulack, J ;
McAlister, VC ;
MacAulay, MA ;
BitterSuermann, H ;
MacDonald, AS ;
Lee, TDG .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1996, 80 (03) :273-277
[28]  
LAMPSON LA, 1980, J IMMUNOL, V125, P293
[29]  
LIBBY P, 1991, LAB INVEST, V64, P5
[30]  
LIBBY P, 1989, TRANSPLANT P, V21, P3677